Mice lacking sulfonylurea receptor 2 (SUR2) ATP-sensitive potassium channels are resistant to acute cardiovascular stress

Journal of Molecular and Cellular Cardiology

Volumn 43, Issue 4, 2007, Pages 445-454

  Stoller, Douglas ^a   Kakkar, Rahul ^a   Smelley, Matthew ^a   Chalupsky, Karel ^a   Earley, Judy U ^a   Shi, Nian Qing ^b   Makielski, Jonathan C ^b   McNally, Elizabeth M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Cardiac stress; KATP channel; Myocardial infarction; Sulfonylurea receptor; Vasospasm

Indexed keywords

ADENOSINE TRIPHOSPHATE; DIAZOXIDE; ISOPRENALINE; NIFEDIPINE; NITRIC OXIDE; POTASSIUM CHANNEL; SULFONYLUREA RECEPTOR; SULFONYLUREA RECEPTOR 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; CARDIOVASCULAR FUNCTION; CELL MEMBRANE; CONTROLLED STUDY; CORONARY ARTERY SPASM; DRUG EFFECT; ELECTROCARDIOGRAM; ESOPHAGUS ACHALASIA; FIBROSIS; HEART PROTECTION; HEART STRESS; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TELEMETRY;

ACUTE DISEASE; ADRENERGIC BETA-AGONISTS; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CALCIUM CHANNEL BLOCKERS; CARDIOMEGALY; CARDIOVASCULAR DISEASES; CORONARY VASOSPASM; CYTOPROTECTION; GENETIC PREDISPOSITION TO DISEASE; ISOPROTERENOL; KATP CHANNELS; MALE; MICE; MICE, KNOCKOUT; MYOCYTES, CARDIAC; NITRIC OXIDE; STRESS;

MUS;

EID: 34548863112     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2007.07.058     Document Type: Article

References (36)

1. + channels. Prog. Biophys. Mol. Biol. 81 (2003) 133-176
2. Kane G.C., Liu X.K., Yamada S., Olson T.M., and Terzic A. Cardiac KATP channels in health and disease. J. Mol. Cell. Cardiol. 38 (2005) 937-943
3. + channels in cardiac muscle. Nature 305 (1983) 147-148
4. Carrasco A.J., Dzeja P.P., Alekseev A.E., Pucar D., Zingman L.V., Abraham M.R., Hodgson D., et al. Adenylate kinase phosphotransfer communicates cellular energetic signals to ATP-sensitive potassium channels. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 7623-7628
5. + channel in vivo. FASEB J. 16 (2002) 102-104
6. Jovanovic S., Du Q., Crawford R.M., Budas G.R., Stagljar I., and Jovanovic A. Glyceraldehyde 3-phosphate dehydrogenase serves as an accessory protein of the cardiac sarcolemmal K(ATP) channel. EMBO Rep. 6 (2005) 848-852
7. Chutkow W.A., Simon M.C., Le Beau M.M., and Burant C.F. Cloning, tissue expression, and chromosomal localization of SUR2, the putative drug-binding subunit of cardiac, skeletal muscle, and vascular KATP channels. Diabetes 45 (1996) 1439-1445
8. Chutkow W.A., Makielski J.C., Nelson D.J., Burant C.F., and Fan Z. Alternative splicing of sur2 exon 17 regulates nucleotide sensitivity of the ATP-sensitive potassium channel. J. Biol. Chem. 274 (1999) 13656-13665
9. Shi N.Q., Ye B., and Makielski J.C. Function and distribution of the SUR isoforms and splice variants. J. Mol. Cell. Cardiol. 39 (2005) 51-60
10. Giblin J.P., Cui Y., Clapp L.H., and Tinker A. Assembly limits the pharmacological complexity of ATP-sensitive potassium channels. J. Biol. Chem. 277 (2002) 13717-13723
11. Morrissey A., Rosner E., Lanning J., Parachuru L., Dhar Chowdhury P., Han S., et al. Immunolocalization of KATP channel subunits in mouse and rat cardiac myocytes and the coronary vasculature. BMC Physiol. 5 (2005) 1
12. + channel. J. Physiol. 499 Pt 3 (1997) 715-720
13. Zingman L.V., Hodgson D.M., Bast P.H., Kane G.C., Perez-Terzic C., Gumina R.J., et al. Kir6.2 is required for adaptation to stress. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 13278-13283
14. + channel knockout compromises the metabolic benefit of exercise training, resulting in cardiac deficits. Diabetes 53 Suppl. 3 (2004) S169-S175
15. Kane G.C., Behfar A., Dyer R.B., O'Cochlain D.F., Liu X.K., Hodgson D.M., et al. KCNJ11 gene knockout of the Kir6.2 KATP channel causes maladaptive remodeling and heart failure in hypertension. Hum. Mol. Genet. 15 (2006) 2285-2297
16. + channels in pressure overload-induced congestive heart failure revealed in KCNJ11 Kir6.2-null mutant. J. Physiol. 577 (2006) 1053-1065
17. Suzuki M., Sasaki N., Miki T., Sakamoto N., Ohmoto-Sekine Y., Tamagawa M., et al. Role of sarcolemmal K(ATP) channels in cardioprotection against ischemia/reperfusion injury in mice. J. Clin. Invest. 109 (2002) 509-516
18. Gross G.J., and Peart J.N. KATP channels and myocardial preconditioning: an update. Am. J. Physiol.: Heart Circ. Physiol. 285 (2003) H921-H930
19. Chutkow W.A., Samuel V., Hansen P.A., Pu J., Valdivia C.R., Makielski J.C., et al. Disruption of Sur2-containing K(ATP) channels enhances insulin-stimulated glucose uptake in skeletal muscle. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 11760-11764
20. Chutkow W.A., Pu J., Wheeler M.T., Wada T., Makielski J.C., Burant C.F., et al. Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 K(ATP) channels. J. Clin. Invest. 110 (2002) 203-208
21. Schyvens C.G., Cowden W.B., Zhang Y., McKenzie K.U., and Whitworth J.A. Hemodynamic effects of the nitric oxide donor DETA/NO in mice. Clin. Exp. Hypertens 26 (2004) 525-535
22. Suzuki M., Li R.A., Miki T., Uemura H., Sakamoto N., Ohmoto-Sekine Y., et al. Functional roles of cardiac and vascular ATP-sensitive potassium channels clarified by Kir6.2-knockout mice. Circ. Res. 88 (2001) 570-577
23. Xiaoke Liu S., Garvan K., Alekseev A.E., Hodgson D., O'Cochlain F., Jahangir A., et al. Syndrome of long QT and sudden death in the catecholamine-challenged, after depolarization-prone KATP channel knockout mice. Circulation 110 (2004)
24. Tong X., Porter L.M., Liu G., Dhar-Chowdhury P., Srivastava S., and Pountney D.J. Consequences of cardiac myocyte-specific ablation of KATP channels in transgenic mice expressing dominant negative Kir6 subunits. Am. J. Physiol.: Heart Circ. Physiol. 291 2 (2006 Aug) H543-H551
25. Wajima T., Beguier B., and Yaguchi M. Effects of cariporide (HOE642) on myocardial infarct size and ventricular arrhythmias in a rat ischemia/reperfusion model: comparison with other drugs. Pharmacology 70 (2004) 68-73
26. + exchange inhibitor, SMP-300, on experimental angina and myocardial infarction models in rats. J. Cardiovasc. Pharmacol. 39 (2002) 234-241
27. Kloner R.A., and Przyklenk K. Progress in cardioprotection: the role of calcium antagonists. Am. J. Cardiol. 66 (1990) 2H-9H
28. Miki T., Nagashima K., Tashiro F., Kotake K., Yoshitomi H., Tamamoto A., et al. Defective insulin secretion and enhanced insulin action in KATP channel-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 10402-10406
29. Gumina R.J., O'Cochlain D.F., Kurtz C.E., Bast P., Pucar D., Mishra P., et al. KATP channel knockout worsens myocardial calcium stress load in vivo and impairs recovery in stunned heart. Am. J. Physiol.: Heart Circ. Physiol. 292 (2007) H1706-H1713
30. Wang S., Cone J., and Liu Y. Dual roles of mitochondrial K(ATP) channels in diazoxide-mediated protection in isolated rabbit hearts. Am. J. Physiol.: Heart Circ. Physiol. 280 (2001) H246-H255
31. Pasdois P., Beauvoit B., Costa A.D., Vinassa B., Tariosse L., Bonoron-Adele S., et al. Sarcoplasmic ATP-sensitive potassium channel blocker HMR1098 protects the ischemic heart: Implication of calcium, complex I, reactive oxygen species and mitochondrial ATP-sensitive potassium channel. J. Mol. Cell. Cardiol. 42 3 (2007 Mar) 631-642
32. Kakkar R., Ye B., Stoller D.A., Smelley M., Shi N.Q., Galles K., et al. Spontaneous coronary vasospasm in KATP mutant mice arises from a smooth muscle-extrinsic process. Circ. Res. 98 (2006) 682-689
33. Du Q., Jovanovic S., Clelland A., Sukhodub A., Budas G., Phelan K., et al. Overexpression of SUR2A generates a cardiac phenotype resistant to ischemia. FASEB J. 20 (2006) 1131-1141
34. + channel. J. Biol. Chem. 278 (2003) 31444-31455
35. Ranki H.J., Budas G.R., Crawford R.M., Davies A.M., and Jovanovic A. 17Beta-estradiol regulates expression of K(ATP) channels in heart-derived H9c2 cells. J. Am. Coll. Cardiol. 40 (2002) 367-374
36. Flagg T.P., Remedi M.S., Masia R., Gomes J., McLerie M., Lopatin A.N., et al. Transgenic overexpression of SUR1 in the heart suppresses sarcolemmal K(ATP). J. Mol. Cell. Cardiol. 39 (2005) 647-656